Back to Search
Start Over
Plasminogen activator inhibitor activity in diarrhoea-associated haemolytic uraemic syndrome
- Source :
- QJM. 87:737-740
- Publication Year :
- 1994
- Publisher :
- Oxford University Press (OUP), 1994.
-
Abstract
- Summary In the haemolytic uraemic syndrome (HUS), platelet microthrombi and deposition of fibrin in glomeruli may contribute to the development of renal failure. The balance of procoagulant and fibrinolytic activities in the renal vasculature may therefore have an important role. We measured plasminogen-activator inhibitor (PAI) activity in the plasma of 81 children with diarrhoea-associated (D+) HUS, and found elevated PAI activity in many patients. When we categorized patients by need for dialysis, only the dialysed group had significantly higher levels of activity, compared with a group of normal controls. We also compared PAI activity with patient outcome after one year, and found that those with a poor outcome had significantly higher PAI activity than those with a good outcome. We suggest that plasma PAI activity may be an acute marker for dialysis requirement in HUS, and may have prognostic value for long-term outcome. The possible role of PAI in the pathogenesis of HUS requires further investigation.
- Subjects :
- Diarrhea
medicine.medical_specialty
Adolescent
medicine.medical_treatment
urologic and male genital diseases
Fibrin
Pathogenesis
Renal Dialysis
Internal medicine
Plasminogen Activator Inhibitor 1
Blood plasma
Humans
Medicine
Platelet
Child
Dialysis
biology
business.industry
Infant
General Medicine
Prognosis
Endocrinology
Child, Preschool
Hemolytic-Uremic Syndrome
biology.protein
medicine.symptom
Haemolytic-uraemic syndrome
business
Plasminogen activator
Biomarkers
Subjects
Details
- ISSN :
- 14602393 and 14602725
- Volume :
- 87
- Database :
- OpenAIRE
- Journal :
- QJM
- Accession number :
- edsair.doi.dedup.....12da6c5c7f153a6d0a8625b2680e79d7